Reason for request
Inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals.
Clinical Benefit
| Moderate |
Le service médical rendu par DICLOFENAC MIKA PHARMA 4% est modéré.
|
Clinical Added Value
| no clinical added value |
La spécialité Diclofénac Mika Pharma 4% n’apporte pas d’amélioration du service médical rendu (ASMR V) par rapport aux autres AINS topiques.
|
eNq9mF1v2jAUhu/5FVHukzSMjjIFqo21G1KrMlq0aTfVITkppsZO/QF0v34OoRqdEnU19S5jO+858Xn9+CjJ6WZJvRUKSTjr+3F45HvIUp4Rdtf3pzfnwYl/OmglC1jB3rJueBTGbd9LKUjZ98vZcIbAZPjj8uIzmvdR+IOWl/DZAlP1bJ1WhIZfQc4voSjXeMmKk8xboprzrO8XWm1HvUQqYbIYrLm4lwWkmES7kf3ZxW1nfzyJSrF/UNUSxQWwu1pRZFaaqRYCmRqCwjsuHhvyfWelTeQEJdcixTGo+VjwFckwqw2RA5VoFSRfZ9coVhRVGaRWPFqkS2klDgvYTPBhVJ/0RzM7VBsVHAVxtxu3j3udXtzuda1Cib2tqq+C+Ygove10u512L0IWZSSlPEcGaSCN+R80BktyD0ExB7EEy4qNuVBAHdWKyOFzuzmKI/DhRU9kRBYUHsOFLGy3CgSYaRQGCu4+pPyCG2EwRc2e/aXPNKXRK7Oe7iDiKOOSUUOumWpgyfnEdiOGnCncNFfUDn9qs/MiQfl2sr84q0f/WM8oSW1BZ1CkUarpZNTMOfeI+AQSp8IdI74TlvG1fHv27NfaUfbFFp+1ooXI4tt27+R9fHxsfbR+GmM13EZnWvACI0MlIg+BzYjl/FDMGK/WSz051bFJt50ST4FiQ68UWHLIuPOptXPmf3dnq5qoFf1ydmNrmm8axeP19rFWmmT9p3LbMdoF+I1DG/N+vd+rY++kidaiHidzpQr5IYrW63U4BxlIMLsU5uI/XQJ7t7G7xt7JlV+1QBVIHaU+q27I19XN9vi91BQc2uju3t811LUxlNB4QC0qUjvj6ejs7RH9p8t1lvb4GVPchdl2pKAIZ656Ij2rVTzoUjBlZefC8OEqz0nDf5ZGWyZR9Y9n0Eqi8v/OoPUbYaEGmw==
UvbcYrX6qtAKCY19
Listen
